Charlie Hatton

14PUBLICATIONS

159CO-AUTHORS

Medical molecular engineering of nucleic acids and proteinsBiologically active moleculesSupramolecular chemistryHaematological tumoursGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|May 08, 2026

CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trials.

|Feb 16, 2026

High-throughput ligand diversification to discover chemical inducers of proximity.

James B Shaum, Miquel Muñoz I Ordoño, Erica A Steen

|Sep 15, 2025

High-throughput diversification of protein-ligand surfaces to discover chemical inducers of proximity.

James B Shaum, Miquel Muñoz I Ordoño, Erica A Steen

|Sep 01, 2025

p300/CBP is an essential driver of pathogenic enhancer activity and gene expression in Ewing sarcoma.

Laura C Godfrey, Brandon Regalado, Sydney R Schweber

|Jun 19, 2025

KAT6A and KAT7 Histone Acetyltransferase Complexes Are Molecular Dependencies and Therapeutic Targets in NUP98-Rearranged Acute Myeloid Leukemia.

Nicole L Michmerhuizen, Emily B Heikamp, Ilaria Iacobucci

|Dec 14, 2023

Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML.

Wallace Bourgeois, Jevon A Cutler, Brandon J Aubrey

Pageof 3

Frequent Collaborators

11 joint publications

Scott A Armstrong

Daniela V Wenge

Eric S Fischer

Yana Pikman

Sarah Naomi Olsen

Yanhe Wen

Florian Perner

Katherine A Donovan

Andrei V Krivtsov

Emily B Heikamp

Frequent Collaborators

11 joint publications

Scott A Armstrong

6 joint publications

Daniela V Wenge

4 joint publications

Eric S Fischer

4 joint publications

Yana Pikman